HyClone̥ţѪSH30088.03

۸Ԫ

500ML 500MLX10

ϵʽI47-825O-882O

ҵ

¡FBSƷϢ

Ʒ: HyClone̥ţѪ()HyClone̥ţѪ HyClone̥ţѪHyCloneFBSHyCloneFBS HyClone FBS()HyClone FBS() ¡̥ţѪ()¡̥ţѪ¡FBS
Ӣ: HyClone Fetal Bovine Serum, Standard, US origin. HyClone FBS, Standard, US origin.
Ʒ: SH30088.03
Ѫȼ: Standard FBS׼
ȼ˵Hyclone׼̥ţѪ壨Standard FBSܹͨϸ󲿷ͨϸʵ̥ţѪͨ3100nmĤ˵ķʹѪϸ޾׼̥ţѪ徭ڶغѪؼͨ˷ţ
ʽ: 3 x 100 nmĤ
Դ: 
Դ: ̥ţ
ڶˮƽ: 
Ѫˮƽ 
δ
ߴ δ
ϸ δ
֧ԭ
ϸ
Ʒ: 500 ML
: -5 to -20°C
䷽ʽ: ɱ
ƷӦ:
Hyclone̥ţѪѪԴͨ USDA֤ѪԴȶɿ
 
Hyclone׼̥ţѪ Characterized FBS, US OriginƷص£ ȫIJƷԴ׷ѪпŨȵͶ ӷḻTP֤ƿƿ֮СIJͨũҵUSDA֤
 
¡׼̥ţѪSH30088.03dz;ȽϹ ڸְϸϸԭϸϸ̥ϸʸϸȣ
Ԫ $595 / ƿ GE Lifesciences
ƷͼƬ Hyclone̥ţѪFBS 16000044
ͼƬ Hyclone̥ţѪFBSͼƬ


۵Hyclone̥ţѪȫ1ڳκβƷ ˻!

ҳ΢ȦqqȺ͸ͷȡѵHyclone̥ţѪ װ20mlװٹ


Hyclone¡̥ţѪʹ÷

ϸ5%-20%̥ţѪʹõHyclone̥ţѪŨ10%ŨȵѪܸıϸĻӰʵĽʵʹ10%ĺ ¡̥ţѪ293TϸЧdzЩϸҲʹ5%Hyclone FBS20%Hyclone̥ţѪҪݾ ϸѡʵHyclone̥ţѪŨ

Hyclone̥ţѪ屣淽

1ҪڱѪ봢-20 - 70 ±4бʱ𳬹1Ѫ 37̫,Ѫû,ͬʱѪеЧɷֻ ƻӰѪһ޷һƿ, 4045mlװ޾50mlĹѪʱԼ10%,,Ѫڶ±ǰԤһ ռ, ׷Ⱦƿ
 
2һ㳧ṩѪΪ޾,ٹ˳緢Ѫ,ɽѪҺһ,ֱ Ѫ
 
3ƿװѪⶳ𲽽ⶳ:-20 -70 ±еѪ4ܽ1.Ȼ,ȫ ܽٷװ,һ50ml޾Ĺܿɷװ4045ml ܽҡξ(С),ʹ¶ ɷ־һ,ķ.ֱӽѪ-2037ⶳ,¶ȸı̫,ɵ ֳ
 
4ָ56, 30ӼȫⶳѪ.ȹҡξ.ȴĿʹѪеIJ ɷ.DZ,һ㲻ȴ,Ϊȴ Ѫ,һӰѪ. 뷴Ӧ:ϸ, ƽϸ, ʴϸѪСͷ鰷, ǿ, ٽܰϸ;ϸ ѧ ͻ
 
5Ѫеij ״:ҪѪе֬ױԼⶳѪά,Щ״ﲻӰѪ屾 .3000rpm,5ȥ,Ҳɲô ΢ "Сڵ":ȴѪ, γɻЩ΢¹۲"Сڵ",ΪѪȾһ,С 㲻Ӱϸ ,Ѫ,Ӧֹͣʹ,һŵѪ
 

Hyclone¡ѪƷֲPDFļ

Hyclone¡̥ţѪFBSƷֲ
Hyclone¡̥ţѪ˵

Hyclone̥ţѪ壨¡FBSϸѡָ

Hyclone̥ţѪFBS
ؼ̥ţѪ壨Defined FBS
Ʒ
̥ţѪ壨Defined FBS, ѪԴ
40 nm޾
ڶ≤10 EU/mLѪ≤10 mg/dL
500 mL SH30070.03
ż̥ţѪ壨Characterized FBS
Ʒ
̥ţѪ壨Characterized FBS, ѪԴ
3 x 100 nm޾
ڶ≤25 EU/mLѪ≤25 mg/dL
500 mL SH30071.03
̥ţѪUSDA֤USDA Tested FBS
3 x 100 nm޾
ڶ≤25 EU/mLѪ≤25 mg/dL
ͨţкѪԴԸ˹鶼˹߶Σ
500 mL SH30910.03
̥ţѪ壨Characterized FBS, ôѪԴ
3 x 100 nm޾
ڶ≤25 EU/mLѪ≤25 mg/dL
500 mL SH30396.03
̥ţѪ壨Characterized FBS, ѪԴ
3 x 100 nm޾
ڶ≤20 EU/mLѪ≤25 mg/dL
500 mL SH30406.02
̥ţѪ壨Characterized FBS, ѪԴ
3 x 100 nm޾
ڶ≤25 EU/mLѪ≤25 mg/dL
500 mL SH30084.03
̥ţѪ壨Characterized FBS, ѪԴ
3 x 100 nm޾
ڶ≤10 EU/mLѪ≤25 mg/dL
500 mL SV30160.03
׼̥ţѪ壨Standard FBS
Ʒ
̥ţѪ壨Standard FBS, ѪԴ
3 x 100 nm޾
ڶغѪм¼
ͨţкBVD
500 mL SH30088.03
;̥ţѪ壨Specialty FBS
Ʒ
̥̿ţѪ壨Charcoal/Dextran Treated FBS, ѪԴ
3 x 100 nm޾
ڶ≤10 EU/mLѪ≤20 mg/dL
500 mL SH30068.03
͸̥ţѪ壨Dialyzed FBS ѪԴ
3 x 100 nm޾
ڶ≤10 EU/mLѪ≤10 mg/dL
≤ Mr 10 000
500 mL SH30079.03
IgG̥ţѪ壨Super Low IgG FBS, ѪԴ
40 nm޾
ڶ≤10 EU/mLѪ≤10 mg/dL
IgG: ≤ 5 μg/mL
500 mL SH30898.03
ר̥ţѪ壨Screened FBS
Ʒ
ESϸר̥ţѪ壨ES Cell Screened FBS, ѪԴ
40 nm޾
ڶ≤10 EU/mLѪ≤10 mg/dL
500 mL SH30070.03E
˹ʸϸר̥ţѪ壨Human Mesenchymal Stem Cell Screened FBSѪԴ
40 nm޾
ڶ≤10 EU/mLѪ≤10 mg/dL
500 mL SH30070.03M
Ļ̥ţѪ壨Tetracycline Screened FBS, ѪԴ
40 nm޾
ڶ≤10 EU/mLѪ≤10 mg/dL
500 mL SH30070.03T
ϸר̥ţѪ壨Insect Cell Screened FBS, ѪԴ
40 nm޾
ڶ≤10 EU/mLѪ≤10 mg/dL
500 mL SH30070.03I
СţѪ壨Bovine Calf Sera
Ʒ
СţѪ壨Bovine Calf Serum, ѪԴ
3 x 100 nm޾
ڶ≤10 EU/mLѪ≤10mg/dL
16-22Сţ
500 mL SH30073.03
СţѪ壨Iron-Supplemented Bovine Calf SerumѪԴ
3 x 100 nm޾
ڶ≤10 EU/mLѪ≤10 mg/dL
16-22Сţ
500 mL SH30072.03
ţѪ壨Newborn Calf Serum, ѪԴ
3 x 100 nm޾
ڶ≤50 EU/mLѪ≤25 mg/dL
Գ10ڵţ
500 mL SH30118.03
ţѪ壨New Zealand Newborn Bovine Calf Serum
3 x 100 nm޾
ڶ≤25 EU/mLѪ≤25 mg/dL
ԳС10ţ
500 mL SH30401.01
СţѪ (New Zealand Iron Supplemented Newborn Serum)
3 x 100 nm޾
ڶ≤25 EU/mLѪ≤25 mg/dL
ԳС10ţ
500 mL SH30626.02
Ѫ壨Engineered sera
Ʒ
ţѪ壨Alpha Calf Fraction, ѪԴ
3 x 100 nm޾
ڶ≤10 EU/mLѪ≤20 mg/dL
500 mL SH30212.03
FetalClone I Ѫ壨FetalClone IѪԴ
3 x 100 nm޾
ڶ≤10 EU/mLѪ≤20 mg/dL
ӽϸhybridoma cellsŻ
500 mL SH30080.03
FetalClone II Ѫ壨FetalClone IIѪԴ
3 x 100 nm޾
ڶ≤10 EU/mLѪ≤20 mg/dL
CHO-K1CHOϵϸŻ
500 mL SH30066.03
FetalClone III Ѫ壨FetalClone IIIѪԴ
3 x 100 nm޾
ڶ≤10 EU/mLѪ≤20 mg/dL
ڴ󲿷ϸԳάϸfibroblasts ellsŻ
500 mL SH30109.03
ţѪ壨Alternatives
Ʒ
СţѪ壨Bovine Growth Serum, ѪԴ
3 x 100 nm޾
ڶ≤10 EU/mLѪ≤10 mg/dL
16-22Сţ
500 mL SH30541.03
ǿСţѪ壨Cosmic Calf Serum, ѪԴ
3 x 100 nm޾
ڶ≤10 EU/mLѪ≤10 mg/dL
16-22Сţ
500 mL SH30087.03
ǿţѪ壨New Zealand Cosmic Calf Serum
3 x 100 nm޾
ڶ≤25 EU/mLѪ≤25 mg/dL
ԳС10ţ
500 mL SH30413.02
Ѫ壨Species-specific sera
Ʒ
ţѪ壨Donor Adult Bovine Serum, ѪԴ
3 x 100 nm޾
ڶ≤50 EU/mLѪ≤25 mg/dL
ԳС36µijţ
500 mL SH30075.03
Ѫ壨Donor Equine SerumDonor Horse Serum, ѪԴ
3 x 100 nm޾
ڶ≤10 EU/mLѪ≤10 mg/dL
Գ6µij
500 mL SH30074.03
Ѫ壨New Zealand Porcine Serum
3 x 200 nm޾˺ͷ
ڶ≤100 EU/mLѪ≤50 mg/dL
Գ6µij
1000 mL SH30908.04
ϸMedia
Ʒ
RPMI 1640 Medium
with 25 mM Hepes and L-glutamine
500 mL SH30255
DMEM
with high glucose, 4.0 mM L-glutamine, and sodium pyruvate
500 mL SH30243
DMEM
with high glucose and 4.0 mM L-glutamine • without sodium pyruvate
500 mL SH30022
DMEM
with high glucose • without L-glutamine and sodium pyruvate
500 mL SH30081
DMEM
with high glucose and L-glutamine • without sodium pyruvate
500 mL SH30003
IMDM
with L-glutamine and HEPES • without alpha-thioglycerol
500 mL SH30228
MEM
with Earle’s balanced salt solution (EBSS) and 2.0 mM L-glutamine
500 mL SH30024
HyQTase
Cell detachment solutionϸҺϸɢҺ
100 mL SV30030
Trypan Blue Solution̨ȾɫҺ
0.4% in phosphate buffered saline
100 mL SV30084
Gentamicin SolutionùҺ
50 mg/mL
10 x 10 mL SV30080
Antibiotic Antimycotic SolutionؿҺ
(Pen/strep/fungizone), 100×
100 mL SV30079
Phosphate Buffered Saline (PBSλҺ) 500 mL SH30256
Dulbecco’s Phosphate Buffered Saline (DPBS) 500 mL SH30264
HEPES
1 M solution
100 mL SH30237
Earle’s Balanced Salt Solution (EBSSҺ)
1×, with calcium, magnesium, phenol red
500 mL SH30029
Hank’s Balanced Salt Solution (HBSSҺ)
1×, with calcium, magnesium, phenol red
500 mL SH30030
L-Glutamine
0.25%
500 mL SH30034
NEAA 100 mL SH30238
Cell Culture Grade Water
ڶ(< 0.005 EU/mL), , ˮ, 100 nm޾
500 mL SH30529

¡FBSƷ˵pdf

¡FBSƷӦþ

ȫ ϸѪ Ʒ

ѪƷ

زƷ

ʴ

Copyright © 20012-2013 BIOFENG. Ȩ Powered by Biofeng
ӭķʺѯ....
Ƶ